Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach

Vania Tacher, MingDe Lin, Rafael Durán, Hooman Yarmohammadi, Howard Lee, Julius Chapiro, Michael Chao, Zhijun Wang, Constantine Frangakis, Jae Ho Sohn, Mitchell Maltenfort, Timothy M. Pawlik, Jean-François GeschwindRadiology 2015 · DOI

Abstract

The 3D-based imaging biomarkers qEASL and vRECIST were tumor response criteria that could be used to predict patient survival early after initial TACE and enabled clear identification of nonresponders.
BibTeX
@inproceedings{tacher2015comparison,
  author = {Vania Tacher and MingDe Lin and Rafael Durán and Hooman Yarmohammadi and Howard Lee and Julius Chapiro and Michael Chao and Zhijun Wang and Constantine Frangakis and Jae Ho Sohn and Mitchell Maltenfort and Timothy M. Pawlik and Jean-François Geschwind},
  title = {{Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach}},
  booktitle = {Radiology},
  year = {2015},
  doi = {10.1148/radiol.2015142951},
}

Loading related content...

Figure